NRIX
Nurix Therapeutics, Inc.NASDAQHealthcare$15.51+0.19%ClosedMarket Cap: $1.34B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | Ring Christine | officer: Chief Legal Officer | Sell | 8,148 | $15.24 | 26,453 |
| Mon Mar 02 | Ring Christine | officer: Chief Legal Officer | Sell | 8,148 | $15.44 | 34,601 |
| Tue Feb 10 | van Houte Hans | officer: Chief Financial Officer | Sell | 93,750 | $16.45 | 93,750 |
| Tue Feb 10 | Ring Christine | officer: Chief Legal Officer | Sell | 93,750 | $16.45 | 93,750 |
| Tue Feb 10 | Ring Christine | officer: Chief Legal Officer | Sell | 42,875 | $0.00 | 42,875 |
| Tue Feb 10 | Hansen Gwenn | officer: Chief Scientific Officer | Sell | 93,750 | $16.45 | 93,750 |
| Tue Feb 10 | Hansen Gwenn | officer: Chief Scientific Officer | Sell | 42,875 | $0.00 | 42,875 |
| Tue Feb 10 | SANDS ARTHUR T | director, officer: President, CEO | Sell | 562,500 | $16.45 | 562,500 |
| Tue Feb 10 | van Houte Hans | officer: Chief Financial Officer | Sell | 42,875 | $0.00 | 42,875 |
| Mon Feb 09 | Ring Christine | officer: Chief Legal Officer | Sell | 14,261 | $16.66 | 42,749 |
| Tue Feb 03 | Hansen Gwenn | officer: Chief Scientific Officer | Sell | 31,333 | $0.84 | 115,005 |